Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 76 clinical trials
Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia

experimental medicine approach. Antipsychotics are the major therapeutic tool for chronic psychotic disorders, including schizophrenia, but do not significantly alter their course or real-life impact. Specific

  • 0 views
  • 26 Jan, 2021
  • 1 location
Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Schizophrenia or Bipolar Illness

disease. In addition, many psychiatric medications, particularly antipsychotics and mood stabilizers, can contribute to metabolic side effects and weight gain. Low-carbohydrate high-fat (LCHF) diets have

psychiatric disorder
hypertriglyceridemia
dietary modification
cardiovascular disease
antipsychotics
  • 249 views
  • 21 Feb, 2021
  • 1 location
Propranolol for Challenging Behaviors in Autism

can be effective in individuals with ASD who display severe aggression and have not responded to antipsychotics or mood stabilizers. Concerns regarding the safety of high dose propranolol have limited

autism
abilify
antipsychotics
propranolol
psychotropic drugs
  • 7 views
  • 23 Jan, 2021
8-week of PS128 RCT in Patients With Major Depressive Disorder

(DSM-V) criteria of major depressive episode in recent 2 years; Psychotropics including antidepressants, antipsychotics and hypnotics have been kept unchanged for at least 1 months. The exclusion

psychiatric disorder
anxiety
major depressive disorder
antipsychotics
schizophrenia
  • 2 views
  • 24 Jan, 2021
  • 1 location
Siltuximab in Schizophrenia

solution for infusion, and will be administered by intravenous infusion. The investigators propose a 9-week randomized controlled trial of siltuximab, given in adjunct to antipsychotics, in N=30

cancer
antipsychotics
schizoaffective disorder
adjunctive treatment
schizophrenia
  • 93 views
  • 24 Jan, 2021
  • 1 location
Neurophysiological Markers of Pediatric Irritability and Its Response to Intervention

medications. The unpredictability in response to CNS stimulants has led to the increasing use of antipsychotics and other non-evidence based treatments for ADHD. It is unknown what drives this heterogeneity

methylphenidate
substance use
behavioral disorder
attention deficit disorder
schizophrenia
  • 79 views
  • 24 Jan, 2021
  • 1 location
Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole

The purpose of this study is the use of magnetoencephalography or MEG (a machine that measures magnetic activity in your brain) and electroencephalography or EEG (a technique that measures electrical activity in your brain) to study how sounds are processed in individuals with schizophrenia prior to initiation with aripiprazole treatment …

scid
psychiatric hospitalization
antipsychotics
risperidone
structured clinical interview
  • 19 views
  • 07 Nov, 2020
  • 1 location
Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease (AD) (THC-AD)

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease of aging. Neuropsychiatric symptoms (NPS) in AD are a major cause of burden to patients, caregivers, and society and are near-universal at some point in the AD course. One of the most troubling of these symptoms is agitation (Agit-AD), typified by …

dementia
psychiatric disorder
neuropsychiatric symptoms
agitation
alzheimer's disease
  • 47 views
  • 24 Jan, 2021
  • 3 locations
Study of Depakote for Behavioral and Psychological Symptoms in Dementia

This prospective, naturalistic, open label study will test the hypothesis that Depakote is correlated with a reduction in elevated Cohen-Mansfield Agitation Index (CMAI) verbal and physical agitation and aggression scales over a 6-week period among patients with elevated scores on those scales, and that these positive results can be achieved …

psychiatric disorder
psychological symptoms
agitation
behavioral problems
antipsychotics
  • 23 views
  • 07 Nov, 2020
  • 1 location
The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial

A short term post-market monitoring of serum prolactin level change among patients with schizophrenia shifting from other antispychotics to different dosages of aripiprazole.

  • 120 views
  • 07 Nov, 2020
  • 1 location